Skip to main content

Lab Notes: Larimar plans $70M stock sale, gets FDA clearance to resume clinical testing

A Villanova-based biotech startup focus on heart disease gets a new CEO
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.